Science Explorer Interactive view Map
Company · San Mateo · United States

Emodo (United States)

Research works
2
fractional, all time
Citations
57
33.3 per fractional work
Top-10% rate
11.3%
record average 16.5%
Open access
49%
world 28%

Not ranked overall: Emodo (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does Emodo (United States) publish most on?

By volume in 2022–2025: Amyotrophic Lateral Sclerosis Research, Genetic Neurodegenerative Diseases, Intensive Care Unit Cognitive Disorders and Infant Development and Preterm Care.

  1. 1 Amyotrophic Lateral Sclerosis Research Neurology 0 works
  2. 2 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
  3. 3 Intensive Care Unit Cognitive Disorders Critical Care and Intensive Care Medicine 0 works
  4. 4 Infant Development and Preterm Care Pediatrics, Perinatology and Child Health 0 works
  5. 5 Lysosomal Storage Disorders Research Physiology 0 works
  6. 6 Glycogen Storage Diseases and Myoclonus Rheumatology 0 works
  7. 7 Gastrointestinal motility and disorders Gastroenterology 0 works
  8. 8 Neonatal and fetal brain pathology Pediatrics, Perinatology and Child Health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.9%not open51.1%

World: 28% of research is openly available.

with international co-authors37.1%domestic only62.9%

World: 19% is written across borders.

Other research institutions in San Mateo

All research institutions in San Mateo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.